114 related articles for article (PubMed ID: 10125703)
1. Annual Pharmaceutical Manufacturers Directory--1993.
Canizares E
Hosp Pharm; 1993 Feb; 28(2):127-8, 130-3, 136-8. PubMed ID: 10125703
[No Abstract] [Full Text] [Related]
2. Annual pharmaceutical manufacturers directory--1994.
Canizares E
Hosp Pharm; 1994 Feb; 29(2):121, 125-8, 131-2 passim. PubMed ID: 10132151
[No Abstract] [Full Text] [Related]
3. Annual pharmaceutical manufacturers' directory--1990.
Canizares E
Hosp Pharm; 1990 Jan; 25(1):11-6. PubMed ID: 10106365
[No Abstract] [Full Text] [Related]
4. Annual pharmaceutical manufacturers directory--1991.
Canizares E
Hosp Pharm; 1991 Jan; 26(1):42-3, 47-8, 51-2 passim. PubMed ID: 10108664
[No Abstract] [Full Text] [Related]
5. Bristol-Myers Squibb drug information department services.
Sylvan L; Palmer-Shevlin N
Hosp Pharm; 1995 Jan; 30(1):38-9, 44. PubMed ID: 10139729
[TBL] [Abstract][Full Text] [Related]
6. Quality of drug information service provided by pharmaceutical manufacturers.
Doyal LE
Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
[No Abstract] [Full Text] [Related]
7. Annual pharmaceutical manufacturers directory--1992.
Canizares E
Hosp Pharm; 1992 Jan; 27(1):23-4, 26, 28-30. PubMed ID: 10116119
[No Abstract] [Full Text] [Related]
8. Annual Pharmaceutical Manufacturers Directory--1995.
Canizares E
Hosp Pharm; 1995 Feb; 30(2):98-100, 103-6, 109-15. PubMed ID: 10140530
[No Abstract] [Full Text] [Related]
9. Emergency telephone numbers of pharmaceutical companies.
Larson RL
Hosp Pharm; 1983 Jul; 18(7):333-8. PubMed ID: 10299064
[No Abstract] [Full Text] [Related]
10. Providing drug information to health professionals and consumers: role and responsibility of the pharmaceutical manufacturer.
Boyland JI
Hosp Pharm; 1983 Apr; 18(4):211-3, 216. PubMed ID: 10260207
[TBL] [Abstract][Full Text] [Related]
11. Disclosure of product information by manufacturers.
Tse CS
Am J Hosp Pharm; 1982 Apr; 39(4):645-6. PubMed ID: 7081244
[No Abstract] [Full Text] [Related]
12. Drug information services at Eli Lilly and Company.
Pfeil-Doyle JL; Jones MD; Oberlin JA; Benitez J
Am J Hosp Pharm; 1990 Sep; 47(9):1996-8. PubMed ID: 2220850
[No Abstract] [Full Text] [Related]
13. Pharmaceutical companies should offer reliable information, not freebies.
Hulstrand EP
Am J Hosp Pharm; 1989 Apr; 46(4):702. PubMed ID: 2719046
[No Abstract] [Full Text] [Related]
14. Pharmaceutical manufacturer's responses to drug information inquiries.
Bainbridge CV; D'Ambrosio GG; Petrick RJ; Weiss EM
Am J Hosp Pharm; 1982 Sep; 39(9):1532-4. PubMed ID: 7137196
[No Abstract] [Full Text] [Related]
15. Third annual directory of pharmaceutical programs.
Biomed Commun; 1976 Mar; 4(2):33-50. PubMed ID: 1026275
[No Abstract] [Full Text] [Related]
16. Internet strategies being implemented by pharmaceutical companies.
Goldstein D; Flory J
Med Interface; 1997 May; 10(5):48-50. PubMed ID: 10167503
[No Abstract] [Full Text] [Related]
17. FDA-USP drug product problem reporting program--an update.
Wheatley LS
Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
[No Abstract] [Full Text] [Related]
18. Better communication urged for pharmaceutical manufacturers.
Woods D
Can Med Assoc J; 1984 Jun; 130(11):1488-9. PubMed ID: 6733620
[No Abstract] [Full Text] [Related]
19. A standard of knowledge for pharmaceutical sales representatives.
Bootman JL
Manag Care Interface; 2006 Oct; 19(10):13. PubMed ID: 17117593
[No Abstract] [Full Text] [Related]
20. Regulating manufacturer-affiliated communication in the information age.
Schulman KA; Abernethy DR; Rathore SS; Woosley RL
Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
